Beer Flavor Provokes Striatal Dopamine Release in Male Drinkers: Mediation by Family History of Alcoholism

Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's cl...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 38; no. 9; pp. 1617 - 1624
Main Authors Oberlin, Brandon G, Dzemidzic, Mario, Tran, Stella M, Soeurt, Christina M, Albrecht, Daniel S, Yoder, Karmen K, Kareken, David A
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism.
AbstractList Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism.
Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [ super(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [ super(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [ super(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism.
Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism.Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism.
Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [ 11 C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [ 11 C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [ 11 C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism.
Author Soeurt, Christina M
Kareken, David A
Albrecht, Daniel S
Oberlin, Brandon G
Tran, Stella M
Yoder, Karmen K
Dzemidzic, Mario
Author_xml – sequence: 1
  givenname: Brandon G
  surname: Oberlin
  fullname: Oberlin, Brandon G
– sequence: 2
  givenname: Mario
  surname: Dzemidzic
  fullname: Dzemidzic, Mario
– sequence: 3
  givenname: Stella M
  surname: Tran
  fullname: Tran, Stella M
– sequence: 4
  givenname: Christina M
  surname: Soeurt
  fullname: Soeurt, Christina M
– sequence: 5
  givenname: Daniel S
  surname: Albrecht
  fullname: Albrecht, Daniel S
– sequence: 6
  givenname: Karmen K
  surname: Yoder
  fullname: Yoder, Karmen K
– sequence: 7
  givenname: David A
  surname: Kareken
  fullname: Kareken, David A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23588036$$D View this record in MEDLINE/PubMed
BookMark eNqNks1v1DAQxS1URLeFE3dkiQsSyuKJk9jhUKm0LEVqBeJD6s1yvBPqrWMHO7vS_vd4-4Gg4sDJ0vg3T29m3gHZ88EjIc-BzYFx-caP47xkwOctPCIzEBUrGl5d7pEZky0vgPPLfXKQ0ooxqEUjn5D9ktdSMt7MyOodYqQLpzch0s8xbMI1Jvp1ilZP2tHTMOrBeqRf0KFOSK2nF9ohPY3WX2NMb-kFLjNrg6fdli4y7bb0zKYpxC0NPT12JlwFZ9PwlDzutUv47O49JN8X77-dnBXnnz58PDk-L0wl6qloOe861sgWRY0AqKtcRlayXvR1ZToBeml0HlxXPQfGpNSyqY3oSwMIfckPydGt7rjuBlwa9FPUTo3RDjpuVdBW_f3j7ZX6ETaKCxB11WSBV3cCMfxcY5rUYJNB57THsE4KKmh5A5WE_0AZa8pStHVGXz5AV2Edfd7EDQX5ViAz9eJP879d318sA3ALmBhSitgrY6eb_edZrFPA1C4VKqdC7VKh2p3L1w967mX_Rf8CI5O4mg
CODEN NEROEW
CitedBy_id crossref_primary_10_1016_j_tips_2014_04_002
crossref_primary_10_1016_j_bcp_2013_07_007
crossref_primary_10_1111_gbb_12349
crossref_primary_10_3389_fnins_2019_00583
crossref_primary_10_1016_j_neubiorev_2019_10_009
crossref_primary_10_1152_jn_00564_2013
crossref_primary_10_1007_s00213_018_4968_7
crossref_primary_10_1080_00952990_2016_1257633
crossref_primary_10_1111_acer_13027
crossref_primary_10_1007_s12561_017_9208_x
crossref_primary_10_1016_j_biopsycho_2016_05_002
crossref_primary_10_1038_npp_2017_298
crossref_primary_10_1016_j_bpsc_2018_03_018
crossref_primary_10_3934_molsci_2021016
crossref_primary_10_1016_j_drugalcdep_2016_01_001
crossref_primary_10_1111_acer_13417
crossref_primary_10_1016_j_neubiorev_2020_04_004
crossref_primary_10_1111_adb_12766
crossref_primary_10_1111_acer_15511
crossref_primary_10_1016_j_pscychresns_2024_111809
crossref_primary_10_1111_acer_15032
crossref_primary_10_1007_s00213_014_3850_5
crossref_primary_10_1007_s11682_018_0023_x
crossref_primary_10_1016_j_bpsc_2016_06_005
crossref_primary_10_1016_j_drugalcdep_2019_02_028
crossref_primary_10_1093_chemse_bjy071
crossref_primary_10_1016_j_pscychresns_2016_01_006
crossref_primary_10_1016_j_drugalcdep_2015_10_021
crossref_primary_10_1016_j_pscychresns_2015_04_010
crossref_primary_10_1111_acer_12515
crossref_primary_10_3390_foods9060821
crossref_primary_10_1111_acer_13403
crossref_primary_10_1111_adb_12599
crossref_primary_10_1016_j_physbeh_2017_09_027
crossref_primary_10_1007_s00213_014_3720_1
crossref_primary_10_1007_s11682_017_9822_8
crossref_primary_10_1038_s41386_021_01157_5
crossref_primary_10_1111_acer_13516
crossref_primary_10_1177_1073191119864659
crossref_primary_10_1002_syn_70007
crossref_primary_10_1016_j_alcohol_2021_01_003
crossref_primary_10_3390_app132212402
crossref_primary_10_1016_j_drugalcdep_2021_108920
crossref_primary_10_1016_j_cobeha_2016_11_011
crossref_primary_10_1111_acer_13158
crossref_primary_10_1016_j_pscychresns_2023_111685
crossref_primary_10_1111_adb_12424
crossref_primary_10_3390_nu14193925
crossref_primary_10_1007_s13311_019_00817_1
crossref_primary_10_1016_j_appet_2019_104486
crossref_primary_10_1007_s11682_015_9374_8
Cites_doi 10.1001/archpsyc.1990.01810180067010
10.1016/j.biopsych.2010.09.049
10.1046/j.1360-0443.2000.9568896.x
10.1016/j.biopsych.2005.04.044
10.1016/j.biopsych.2010.06.005
10.1081/SCC-120034174
10.2174/157340511795445694
10.1523/JNEUROSCI.1544-06.2006
10.3758/BF03342209
10.1111/j.1369-1600.2012.00464.x
10.1111/j.1530-0277.1999.tb04082.x
10.1097/01.WCB.0000085441.37552.CA
10.1097/JCP.0b013e3181e75cff
10.1111/j.1471-4159.2005.03137.x
10.1002/syn.890130407
10.1111/j.1530-0277.2008.00821.x
10.1016/j.pharmthera.2004.06.002
10.1097/00004647-200109000-00002
10.1002/syn.10226
10.1016/j.neuroimage.2009.11.076
10.1001/archpsyc.61.12.1246
10.1007/s00213-006-0578-x
10.1023/A:1020266306135
10.1038/sj.npp.1301513
10.1016/S0893-133X(02)00366-4
10.1523/JNEUROSCI.22-14-06247.2002
10.1016/j.jneumeth.2006.05.035
10.1016/j.tins.2007.03.007
10.1038/mp.2010.56
10.1016/S0166-4328(02)00282-6
10.1038/sj.jcbfm.9600493
10.1038/nature01476
10.1001/archpsyc.60.7.727
10.1007/s00213-004-1828-4
10.1016/j.neuroimage.2012.02.006
10.1093/chemse/21.3.323
10.1002/ana.20822
10.1016/0306-4522(95)00255-H
10.1038/npp.2009.129
10.1016/j.neuroimage.2007.09.059
10.15288/jsa.1994.55.149
10.1097/01.ALC.0000089959.66222.B8
10.1523/JNEUROSCI.5578-03.2004
10.1038/sj.npp.1301194
10.1111/j.1530-0277.2006.00130.x
10.1523/JNEUROSCI.3371-07.2007
10.1111/j.1460-9568.2011.07642.x
10.1016/j.neuroimage.2006.11.043
10.1111/j.1360-0443.2008.02250.x
10.1037/0021-843X.106.2.243
ContentType Journal Article
Copyright Copyright Nature Publishing Group Aug 2013
Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology
Copyright_xml – notice: Copyright Nature Publishing Group Aug 2013
– notice: Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
7QR
8FD
FR3
P64
5PM
DOI 10.1038/npp.2013.91
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
ProQuest Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
Chemoreception Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Chemoreception Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList MEDLINE
Chemoreception Abstracts
ProQuest One Psychology
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Beer flavor provokes striatal dopamine release
EISSN 1740-634X
EndPage 1624
ExternalDocumentID PMC3717546
3020276531
23588036
10_1038_npp_2013_91
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Indiana
United States--US
Indianapolis Indiana
GeographicLocations_xml – name: United States--US
– name: Indiana
– name: Indianapolis Indiana
GrantInformation_xml – fundername: NIAAA NIH HHS
  grantid: P60 AA007611
– fundername: NIAAA NIH HHS
  grantid: R01 AA018354
– fundername: NIAAA NIH HHS
  grantid: T32 AA007462
– fundername: NCATS NIH HHS
  grantid: TR000006
– fundername: NIAAA NIH HHS
  grantid: R01 AA017661
– fundername: NCATS NIH HHS
  grantid: UL1 TR000006
GroupedDBID ---
-DZ
-Q-
0R~
29N
2WC
36B
39C
4.4
406
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AANZL
AASML
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
ADFRT
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
ATHPR
AVWKF
AYFIA
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDB
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
MK0
NQJWS
O9-
OK1
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
--K
1B1
53G
5VS
AACDK
AAEDT
AALRI
AAQFI
AAQXK
AATNV
AAXUO
ABMAC
ABWVN
ACIUM
ACRPL
ADMUD
ADNMO
AILAN
CAG
CGR
COF
CUY
CVF
ECM
EIF
FEDTE
FGOYB
FIGPU
HVGLF
IHE
LGEZI
LOTEE
M41
NADUK
NPM
NQ-
NXXTH
R2-
RIG
RNS
RPZ
SEW
SSZ
ZKB
3V.
7TK
7XB
8FE
8FH
8FK
ABRTQ
K9.
LK8
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
PUEGO
7QR
8FD
FR3
P64
5PM
ID FETCH-LOGICAL-c475t-933bb0689e75e11ea4475e020f7f54cb71adca038a4f310088a865c7f2c1e1f23
IEDL.DBID 7X7
ISSN 0893-133X
1740-634X
IngestDate Thu Aug 21 13:47:29 EDT 2025
Fri Jul 11 06:28:54 EDT 2025
Sun Aug 24 04:11:26 EDT 2025
Fri Jul 25 08:54:32 EDT 2025
Thu Apr 03 06:52:58 EDT 2025
Tue Jul 01 01:05:25 EDT 2025
Thu Apr 24 23:03:14 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c475t-933bb0689e75e11ea4475e020f7f54cb71adca038a4f310088a865c7f2c1e1f23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.nature.com/articles/npp201391.pdf
PMID 23588036
PQID 1400189318
PQPubID 33935
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3717546
proquest_miscellaneous_1419361481
proquest_miscellaneous_1400622795
proquest_journals_1400189318
pubmed_primary_23588036
crossref_citationtrail_10_1038_npp_2013_91
crossref_primary_10_1038_npp_2013_91
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-08-01
PublicationDateYYYYMMDD 2013-08-01
PublicationDate_xml – month: 08
  year: 2013
  text: 2013-08-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2013
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References H Myrick (BFnpp201391_CR34) 2010; 30
ND Volkow (BFnpp201391_CR45) 2006; 26
F Weiss (BFnpp201391_CR48) 1993; 267
ED London (BFnpp201391_CR27) 1990; 47
MS Brodie (BFnpp201391_CR6) 1999; 23
SN Haber (BFnpp201391_CR19) 2010; 35
M Ichise (BFnpp201391_CR20) 2003; 23
KK Yoder (BFnpp201391_CR53) 2009; 33
SF Tapert (BFnpp201391_CR43) 2003; 60
WM Doyon (BFnpp201391_CR10) 2005; 93
DF Wong (BFnpp201391_CR49) 2006; 31
AH Evans (BFnpp201391_CR12) 2006; 59
RB Innis (BFnpp201391_CR21) 2007; 27
C Besson (BFnpp201391_CR3) 1995; 68
MM Andrews (BFnpp201391_CR1) 2011; 69
WM Doyon (BFnpp201391_CR11) 2003; 27
D Martinez (BFnpp201391_CR30) 2005; 58
EG Singleton (BFnpp201391_CR42) 2000
RA Gonzales (BFnpp201391_CR16) 2004; 103
LJ Porrino (BFnpp201391_CR37) 2004; 24
NL Cooney (BFnpp201391_CR8) 1997; 106
J Joutsa (BFnpp201391_CR23) 2012; 60
ND Volkow (BFnpp201391_CR46) 2007; 27
KK Bucholz (BFnpp201391_CR7) 1994; 55
W Schultz (BFnpp201391_CR41) 2007; 30
L Marciani (BFnpp201391_CR28) 2006; 158
JD Salamone (BFnpp201391_CR39) 2002; 137
M Leyton (BFnpp201391_CR25) 2002; 27
O Mawlawi (BFnpp201391_CR31) 2001; 21
CA Munro (BFnpp201391_CR32) 2006; 30
J Garcia (BFnpp201391_CR15) 1966; 4
DA Kareken (BFnpp201391_CR24) 2010; 50
R Ito (BFnpp201391_CR22) 2002; 22
C Martin-Soelch (BFnpp201391_CR29) 2011; 33
PE Phillips (BFnpp201391_CR36) 2003; 422
JI Nurnberger Jr (BFnpp201391_CR35) 2004; 61
NB Urban (BFnpp201391_CR44) 2010; 68
VA Ramchandani (BFnpp201391_CR38) 2011; 16
J Wrase (BFnpp201391_CR50) 2007; 35
ND Volkow (BFnpp201391_CR47) 2008; 39
JM Murphy (BFnpp201391_CR33) 2002; 32
MD Litt (BFnpp201391_CR26) 2000; 95
I Boileau (BFnpp201391_CR5) 2003; 49
FM Filbey (BFnpp201391_CR14) 2008; 33
BFnpp201391_CR13
SM Grüsser (BFnpp201391_CR18) 2004; 175
BG Green (BFnpp201391_CR17) 1996; 21
KK Yoder (BFnpp201391_CR51) 2004; 45
KC Berridge (BFnpp201391_CR2) 2007; 191
JP Schacht (BFnpp201391_CR40) 2012; 18
KK Yoder (BFnpp201391_CR52) 2011; 7
SL Dewey (BFnpp201391_CR9) 1993; 13
JM Bjork (BFnpp201391_CR4) 2008; 103
16971900 - Neuropsychopharmacology. 2006 Dec;31(12):2716-27
20678752 - Biol Psychiatry. 2010 Oct 15;68(8):689-96
17653109 - Neuropsychopharmacology. 2008 May;33(6):1391-401
21126735 - Biol Psychiatry. 2011 Apr 1;69(7):675-83
10591603 - Alcohol Clin Exp Res. 1999 Nov;23(11):1848-52
22348881 - Neuroimage. 2012 May 1;60(4):1992-9
15071103 - J Neurosci. 2004 Apr 7;24(14):3554-62
18851716 - Addiction. 2008 Aug;103(8):1308-19
12827641 - Synapse. 2003 Sep 15;49(4):226-31
15583116 - Arch Gen Psychiatry. 2004 Dec;61(12):1246-56
17291784 - Neuroimage. 2007 Apr 1;35(2):787-94
8670711 - Chem Senses. 1996 Jun;21(3):323-34
18003850 - J Neurosci. 2007 Nov 14;27(46):12700-6
20004725 - Neuroimage. 2010 Mar;50(1):267-76
12687000 - Nature. 2003 Apr 10;422(6932):614-8
16839610 - J Neurosci Methods. 2006 Dec 15;158(2):186-94
8480281 - Synapse. 1993 Apr;13(4):350-6
12973026 - J Cereb Blood Flow Metab. 2003 Sep;23(9):1096-112
15935063 - J Neurochem. 2005 Jun;93(6):1469-81
10946438 - Addiction. 2000 Jun;95(6):889-900
11524609 - J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57
16792561 - Alcohol Clin Exp Res. 2006 Jul;30(7):1143-51
18976347 - Alcohol Clin Exp Res. 2009 Jan;33(1):139-49
12464459 - Neuropsychopharmacology. 2002 Dec;27(6):1027-35
15136642 - J Nucl Med. 2004 May;45(5):903-11
15369680 - Pharmacol Ther. 2004 Aug;103(2):121-46
14574227 - Alcohol Clin Exp Res. 2003 Oct;27(10):1573-82
15127179 - Psychopharmacology (Berl). 2004 Sep;175(3):296-302
22574861 - Addict Biol. 2013 Jan;18(1):121-33
20571434 - J Clin Psychopharmacol. 2010 Aug;30(4):365-72
8189735 - J Stud Alcohol. 1994 Mar;55(2):149-58
2350209 - Arch Gen Psychiatry. 1990 Jun;47(6):567-74
12445713 - Behav Brain Res. 2002 Dec 2;137(1-2):3-25
12405517 - Behav Genet. 2002 Sep;32(5):363-88
17072591 - Psychopharmacology (Berl). 2007 Apr;191(3):391-431
17519979 - J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
21453423 - Eur J Neurosci. 2011 May;33(9):1706-15
12122083 - J Neurosci. 2002 Jul 15;22(14):6247-53
8545002 - Neuroscience. 1995 Oct;68(4):963-8
9131844 - J Abnorm Psychol. 1997 May;106(2):243-50
8229752 - J Pharmacol Exp Ther. 1993 Oct;267(1):250-8
18024160 - Neuroimage. 2008 Feb 1;39(3):1266-73
16557571 - Ann Neurol. 2006 May;59(5):852-8
12860777 - Arch Gen Psychiatry. 2003 Jul;60(7):727-35
17400301 - Trends Neurosci. 2007 May;30(5):203-10
19812543 - Neuropsychopharmacology. 2010 Jan;35(1):4-26
16018986 - Biol Psychiatry. 2005 Nov 15;58(10):779-86
20479755 - Mol Psychiatry. 2011 Aug;16(8):809-17
16775146 - J Neurosci. 2006 Jun 14;26(24):6583-8
References_xml – volume: 47
  start-page: 567
  year: 1990
  ident: BFnpp201391_CR27
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1990.01810180067010
– volume: 69
  start-page: 675
  year: 2011
  ident: BFnpp201391_CR1
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.09.049
– volume: 95
  start-page: 889
  year: 2000
  ident: BFnpp201391_CR26
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.2000.9568896.x
– volume-title: Alcohol Craving Questionnaire (ACQ-NOW): Background, Scoring, and Administration
  year: 2000
  ident: BFnpp201391_CR42
– volume: 58
  start-page: 779
  year: 2005
  ident: BFnpp201391_CR30
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2005.04.044
– volume: 68
  start-page: 689
  year: 2010
  ident: BFnpp201391_CR44
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.06.005
– ident: BFnpp201391_CR13
  doi: 10.1081/SCC-120034174
– volume: 7
  start-page: 118
  year: 2011
  ident: BFnpp201391_CR52
  publication-title: Curr Med Imag Rev
  doi: 10.2174/157340511795445694
– volume: 26
  start-page: 6583
  year: 2006
  ident: BFnpp201391_CR45
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1544-06.2006
– volume: 4
  start-page: 123
  year: 1966
  ident: BFnpp201391_CR15
  publication-title: Psychonomic Science
  doi: 10.3758/BF03342209
– volume: 18
  start-page: 121
  year: 2012
  ident: BFnpp201391_CR40
  publication-title: Addict Biol
  doi: 10.1111/j.1369-1600.2012.00464.x
– volume: 23
  start-page: 1848
  year: 1999
  ident: BFnpp201391_CR6
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.1999.tb04082.x
– volume: 23
  start-page: 1096
  year: 2003
  ident: BFnpp201391_CR20
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1097/01.WCB.0000085441.37552.CA
– volume: 30
  start-page: 365
  year: 2010
  ident: BFnpp201391_CR34
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/JCP.0b013e3181e75cff
– volume: 93
  start-page: 1469
  year: 2005
  ident: BFnpp201391_CR10
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2005.03137.x
– volume: 13
  start-page: 350
  year: 1993
  ident: BFnpp201391_CR9
  publication-title: Synapse
  doi: 10.1002/syn.890130407
– volume: 33
  start-page: 139
  year: 2009
  ident: BFnpp201391_CR53
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2008.00821.x
– volume: 103
  start-page: 121
  year: 2004
  ident: BFnpp201391_CR16
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2004.06.002
– volume: 45
  start-page: 903
  year: 2004
  ident: BFnpp201391_CR51
  publication-title: J Nucl Med
– volume: 21
  start-page: 1034
  year: 2001
  ident: BFnpp201391_CR31
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1097/00004647-200109000-00002
– volume: 49
  start-page: 226
  year: 2003
  ident: BFnpp201391_CR5
  publication-title: Synapse
  doi: 10.1002/syn.10226
– volume: 50
  start-page: 267
  year: 2010
  ident: BFnpp201391_CR24
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2009.11.076
– volume: 61
  start-page: 1246
  year: 2004
  ident: BFnpp201391_CR35
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.61.12.1246
– volume: 191
  start-page: 391
  year: 2007
  ident: BFnpp201391_CR2
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-006-0578-x
– volume: 32
  start-page: 363
  year: 2002
  ident: BFnpp201391_CR33
  publication-title: Behav Genet
  doi: 10.1023/A:1020266306135
– volume: 33
  start-page: 1391
  year: 2008
  ident: BFnpp201391_CR14
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301513
– volume: 27
  start-page: 1027
  year: 2002
  ident: BFnpp201391_CR25
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(02)00366-4
– volume: 22
  start-page: 6247
  year: 2002
  ident: BFnpp201391_CR22
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-14-06247.2002
– volume: 158
  start-page: 186
  year: 2006
  ident: BFnpp201391_CR28
  publication-title: J Neurosci Methods
  doi: 10.1016/j.jneumeth.2006.05.035
– volume: 30
  start-page: 203
  year: 2007
  ident: BFnpp201391_CR41
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2007.03.007
– volume: 16
  start-page: 809
  year: 2011
  ident: BFnpp201391_CR38
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2010.56
– volume: 137
  start-page: 3
  year: 2002
  ident: BFnpp201391_CR39
  publication-title: Behav Brain Res
  doi: 10.1016/S0166-4328(02)00282-6
– volume: 27
  start-page: 1533
  year: 2007
  ident: BFnpp201391_CR21
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/sj.jcbfm.9600493
– volume: 422
  start-page: 614
  year: 2003
  ident: BFnpp201391_CR36
  publication-title: Nature
  doi: 10.1038/nature01476
– volume: 60
  start-page: 727
  year: 2003
  ident: BFnpp201391_CR43
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.60.7.727
– volume: 175
  start-page: 296
  year: 2004
  ident: BFnpp201391_CR18
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-004-1828-4
– volume: 60
  start-page: 1992
  year: 2012
  ident: BFnpp201391_CR23
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2012.02.006
– volume: 267
  start-page: 250
  year: 1993
  ident: BFnpp201391_CR48
  publication-title: J Pharmacol Exp Ther
– volume: 21
  start-page: 323
  year: 1996
  ident: BFnpp201391_CR17
  publication-title: Chem Senses
  doi: 10.1093/chemse/21.3.323
– volume: 59
  start-page: 852
  year: 2006
  ident: BFnpp201391_CR12
  publication-title: Ann Neurol
  doi: 10.1002/ana.20822
– volume: 68
  start-page: 963
  year: 1995
  ident: BFnpp201391_CR3
  publication-title: Neuroscience
  doi: 10.1016/0306-4522(95)00255-H
– volume: 35
  start-page: 4
  year: 2010
  ident: BFnpp201391_CR19
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2009.129
– volume: 39
  start-page: 1266
  year: 2008
  ident: BFnpp201391_CR47
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2007.09.059
– volume: 55
  start-page: 149
  year: 1994
  ident: BFnpp201391_CR7
  publication-title: J Stud Alcohol
  doi: 10.15288/jsa.1994.55.149
– volume: 27
  start-page: 1573
  year: 2003
  ident: BFnpp201391_CR11
  publication-title: Alcohol Clin Exp Res
  doi: 10.1097/01.ALC.0000089959.66222.B8
– volume: 24
  start-page: 3554
  year: 2004
  ident: BFnpp201391_CR37
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5578-03.2004
– volume: 31
  start-page: 2716
  year: 2006
  ident: BFnpp201391_CR49
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301194
– volume: 30
  start-page: 1143
  year: 2006
  ident: BFnpp201391_CR32
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2006.00130.x
– volume: 27
  start-page: 12700
  year: 2007
  ident: BFnpp201391_CR46
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3371-07.2007
– volume: 33
  start-page: 1706
  year: 2011
  ident: BFnpp201391_CR29
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2011.07642.x
– volume: 35
  start-page: 787
  year: 2007
  ident: BFnpp201391_CR50
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2006.11.043
– volume: 103
  start-page: 1308
  year: 2008
  ident: BFnpp201391_CR4
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2008.02250.x
– volume: 106
  start-page: 243
  year: 1997
  ident: BFnpp201391_CR8
  publication-title: J Abnorm Psychol
  doi: 10.1037/0021-843X.106.2.243
– reference: 8545002 - Neuroscience. 1995 Oct;68(4):963-8
– reference: 15071103 - J Neurosci. 2004 Apr 7;24(14):3554-62
– reference: 18851716 - Addiction. 2008 Aug;103(8):1308-19
– reference: 20571434 - J Clin Psychopharmacol. 2010 Aug;30(4):365-72
– reference: 12445713 - Behav Brain Res. 2002 Dec 2;137(1-2):3-25
– reference: 16839610 - J Neurosci Methods. 2006 Dec 15;158(2):186-94
– reference: 15136642 - J Nucl Med. 2004 May;45(5):903-11
– reference: 19812543 - Neuropsychopharmacology. 2010 Jan;35(1):4-26
– reference: 20004725 - Neuroimage. 2010 Mar;50(1):267-76
– reference: 16018986 - Biol Psychiatry. 2005 Nov 15;58(10):779-86
– reference: 8229752 - J Pharmacol Exp Ther. 1993 Oct;267(1):250-8
– reference: 18024160 - Neuroimage. 2008 Feb 1;39(3):1266-73
– reference: 12405517 - Behav Genet. 2002 Sep;32(5):363-88
– reference: 10946438 - Addiction. 2000 Jun;95(6):889-900
– reference: 22348881 - Neuroimage. 2012 May 1;60(4):1992-9
– reference: 17653109 - Neuropsychopharmacology. 2008 May;33(6):1391-401
– reference: 8189735 - J Stud Alcohol. 1994 Mar;55(2):149-58
– reference: 2350209 - Arch Gen Psychiatry. 1990 Jun;47(6):567-74
– reference: 12464459 - Neuropsychopharmacology. 2002 Dec;27(6):1027-35
– reference: 8480281 - Synapse. 1993 Apr;13(4):350-6
– reference: 17400301 - Trends Neurosci. 2007 May;30(5):203-10
– reference: 12687000 - Nature. 2003 Apr 10;422(6932):614-8
– reference: 14574227 - Alcohol Clin Exp Res. 2003 Oct;27(10):1573-82
– reference: 9131844 - J Abnorm Psychol. 1997 May;106(2):243-50
– reference: 15583116 - Arch Gen Psychiatry. 2004 Dec;61(12):1246-56
– reference: 22574861 - Addict Biol. 2013 Jan;18(1):121-33
– reference: 10591603 - Alcohol Clin Exp Res. 1999 Nov;23(11):1848-52
– reference: 20678752 - Biol Psychiatry. 2010 Oct 15;68(8):689-96
– reference: 16775146 - J Neurosci. 2006 Jun 14;26(24):6583-8
– reference: 21126735 - Biol Psychiatry. 2011 Apr 1;69(7):675-83
– reference: 17291784 - Neuroimage. 2007 Apr 1;35(2):787-94
– reference: 12827641 - Synapse. 2003 Sep 15;49(4):226-31
– reference: 12122083 - J Neurosci. 2002 Jul 15;22(14):6247-53
– reference: 12973026 - J Cereb Blood Flow Metab. 2003 Sep;23(9):1096-112
– reference: 8670711 - Chem Senses. 1996 Jun;21(3):323-34
– reference: 16557571 - Ann Neurol. 2006 May;59(5):852-8
– reference: 16792561 - Alcohol Clin Exp Res. 2006 Jul;30(7):1143-51
– reference: 15127179 - Psychopharmacology (Berl). 2004 Sep;175(3):296-302
– reference: 12860777 - Arch Gen Psychiatry. 2003 Jul;60(7):727-35
– reference: 17519979 - J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
– reference: 18003850 - J Neurosci. 2007 Nov 14;27(46):12700-6
– reference: 20479755 - Mol Psychiatry. 2011 Aug;16(8):809-17
– reference: 11524609 - J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57
– reference: 15935063 - J Neurochem. 2005 Jun;93(6):1469-81
– reference: 18976347 - Alcohol Clin Exp Res. 2009 Jan;33(1):139-49
– reference: 21453423 - Eur J Neurosci. 2011 May;33(9):1706-15
– reference: 15369680 - Pharmacol Ther. 2004 Aug;103(2):121-46
– reference: 17072591 - Psychopharmacology (Berl). 2007 Apr;191(3):391-431
– reference: 16971900 - Neuropsychopharmacology. 2006 Dec;31(12):2716-27
SSID ssj0015768
Score 2.3502355
Snippet Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1617
SubjectTerms Adult
Alcohol use
Alcoholism
Alcoholism - genetics
Alcoholism - psychology
Beer
Behavior, Addictive - metabolism
Behavior, Addictive - psychology
Brain
Conditioning, Classical
Corpus Striatum - metabolism
Cues
Dopamine
Dopamine - metabolism
Dopamine Antagonists
Ethanol
Family Health
Functional Neuroimaging
Genetic Predisposition to Disease - genetics
Humans
Intoxication
Male
Medicine
Neurosciences
Original
Raclopride
Tomography
Title Beer Flavor Provokes Striatal Dopamine Release in Male Drinkers: Mediation by Family History of Alcoholism
URI https://www.ncbi.nlm.nih.gov/pubmed/23588036
https://www.proquest.com/docview/1400189318
https://www.proquest.com/docview/1400622795
https://www.proquest.com/docview/1419361481
https://pubmed.ncbi.nlm.nih.gov/PMC3717546
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED7BJiFeEHT8KIzJSNMe0MLiOIkdXlDHVk1InaqxSX2LbMfRCmtSkm5S_nvOTppRQHvOxYlydu473_n7APbRsRl3_HaJNB4icO0pzIQ8qSMRKJ4HmSvFTM7js6vw2yyadRtudddWuf4nuh91Vmq7R36EiYBPMbhS8WX5y7OqUba62kloPIZtS11mW7r4rE-4qMXSDkUmzMNcbNadz_OZOCqWlqySsk8J3YxI_8DMv7sl_wg_4-fwrMONZNQ6-gU8MsUAdkYF5syLhhwQ18nptsgH8GTSFcwHcDBtqambQ3J5f9KqPnR39KTVzQ78ODamIuMbeVdWZFqVd-VPU5PvVtQD4Tk5wdx6gSOSCwxTGPjIvCATjC3kpMJkFiHkZzJxoh_oZqIa0uppkJaEpCFlTkatFu-8XryEq_Hp5dczr9Nh8HTIo5WXMKaUH4vE8MhQaqQlCTSIM3OeR6FWnMpMS_yqMsxtvUAIKeJIo6M1NTQP2CvYKsrCvAHCVahjESWSWsLgQKswx6G1b3jGhEr8IXxc-yLVHUm51cq4SV2xnIkUHZdax6UJHcJ-b7xsuTn-b7a7dmraLdA6vZ9OQ_jQX8alZeslsjDlbWsTW4bF6CEbRMCWTBUf87qdJ_272FPIAhHCEPjGDOoNLLX35pVifu0ovhlm2VEYv3341d_B08Cpc9h-xF3YWlW35j1ipJXacwthD7aPT8-nF78BscETXA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD6aOgl4QdBxKQww0tgDWrY4VwcJoY6u6thSVaOT-hYSxxGFNSlJN5Q_xW_k2LmMAtrbnnPqWjrHPt_nY38HYAcdG7tK384LhYYInGsRMiEt5DYzIjcxYlWK8cfO6Nz6NLNnG_CreQsjr1U2e6LaqOOMyzPyAyQCOsXkStmH5Q9Ndo2S1dWmhUYVFiei_ImUrXh_PED_vjGM4dH040iruwpo3HLtlYYMPop0h3nCtQWlIpSSdwJRU-ImtsUjl4YxD3WThVYiT78ZC5ljc5w2p4ImUugAt_xNy0Qq04HNw6Px5KytW0j0rnCrZ2rI_mb1i0Ac7SBdSnlMau57dD0H_gNs_76f-UfCGz6A-zVSJf0qtB7Chki7sNVPkaUvSrJL1N1RdSjfhTt-XaLvwu6kEsMu98j0-m1Xsad-0cpkl1vw7VCInAwvwqssJ5M8u8q-i4J8lm1EkBCQAbL5BY5IzjAxYqol85T4mM3IIEf6jKD1HfFVmxEMLBKVpOrgQSrZk5JkCelX3X_nxeIRnN-Kjx5DJ81S8RSIG1ncYbYXUilRbPDISnBorgs3Nlnk6T142_gi4LUsuuzOcRGo8rzJAnRcIB0XeLQHO63xslID-b_ZduPUoN4SiuA6gHvwuv2Mi1lWaMJUZJeVjSM1He2bbBBzS_lW_JsnVZy0c5Hvnhlikh64axHUGkgx8fUv6fyrEhU3kdfblvPs5qm_grujqX8anB6PT57DPUP1BpG3Ibehs8ovxQtEaKvoZb0sCHy57ZX4G-axT1M
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIU28IOj4KAww0tgDWmicxLGDhFChVBujUwWb1LdgO44orElJuqH8a_x1nJ2PUUB723OuTqq7893Pd_4dQrug2IRZfrtIaAcycOVIQEKOUJR7kqVeYksxk-Pw4DT4MKOzDfSrvQtj2irbPdFu1EmuzBn5AICASyC4Ej5Im7aI6Wj8ZvnDMROkTKW1HadRm8iRrn4CfCtfH45A1889b_z-5N2B00wYcFTA6MoBNC-lG_JIM6oJ0cLQ32nIoFKW0kBJRkSihOtzEaTmJJxzwUOq4C8ooklqSA9g-7_BfEqMj7FZB_aIyeNtBhv5DuDAWXM3ENYaZEtDlEn8lxFZj4b_pLh_d2r-EfrGt9GtJmfFw9rI7qANnfXQ9jADvL6o8B62XaT2eL6HtiZNsb6H9qY1LXa1j08ub3mV-_YXHWF2tY2-vdW6wOMzcZEXeFrkF_l3XeLPZqAIQAM8Aly_gBXxJwiREHTxPMMTiGt4VACQhvT1FZ7YgSNgYlhWuJ7lgWsClArnKR7Wc4Dn5eIuOr0WDd1Dm1me6QcIMxmokNNIEENW7CkZpLC0cjVLfC4jt49etLqIVUOQbuZ0nMW2UO_zGBQXG8XFEemj3U54WfOC_F9sp1Vq3GwOZXxpyn30rHsMbm1qNSLT-XktExp2R3qVDGTfhsgVXnO_tpPuW8wNaA7ZSR-xNQvqBAyt-PqTbP7V0ov7gPBpED68-tOfoi3wv_jj4fHRI3TTs0NCTFvkDtpcFef6MaRqK_nE-gRGX67bCX8DtpNSIw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beer+flavor+provokes+striatal+dopamine+release+in+male+drinkers%3A+mediation+by+family+history+of+alcoholism&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Oberlin%2C+Brandon+G&rft.au=Dzemidzic%2C+Mario&rft.au=Tran%2C+Stella+M&rft.au=Soeurt%2C+Christina+M&rft.date=2013-08-01&rft.eissn=1740-634X&rft.volume=38&rft.issue=9&rft.spage=1617&rft_id=info:doi/10.1038%2Fnpp.2013.91&rft_id=info%3Apmid%2F23588036&rft.externalDocID=23588036
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon